Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCentaur Regulatory News (CAU)

Share Price Information for Centaur (CAU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 40.00
Bid: 39.00
Ask: 41.00
Change: 0.50 (1.27%)
Spread: 2.00 (5.128%)
Open: 39.50
High: 40.00
Low: 39.50
Prev. Close: 40.00
CAU Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

2020 trading update and full-year outlook

28 Oct 2020 07:00

RNS Number : 3990D
Centaur Media PLC
28 October 2020
 

Centaur Media plc

Incorporated in England and Wales

Registration number: 04948078

LEI: 2138005WK87G7DQRQI62

ISIN: GB0034291418

28 October 2020

Centaur Media Plc

(the "Company" or the "Group")

2020 trading update and full-year outlook

Centaur Media Plc, an international provider of business information and specialist consultancy, is pleased to announce an update on trading up to the period ended 30 September 2020. The Company is also providing its outlook for the year to 31 December 2020.

Trading update

Despite the severe impact of COVID-19, the Group's overall performance has been resilient. Excluding the telemarketing activities of MarketMakers which closed in August 2020, revenue in the third quarter was 16% down on the same period in 2019 (compared to down 24% in Q2) and the Group ended the quarter with a strong cash balance of £9.3m at 30 September 2020. This performance reflects decisive action taken following the onset of the pandemic to protect the Group's brands, conserve cash and adapt to the new environment.

2020 full-year outlook

The Board expects to report full-year revenues from continuing operations1 of at least £32m with an adjusted2 EBITDA margin of c.10%, which includes an improved H2 margin compared to H1 2020.

Xeim, our business serving the marketing sector, is expected to report a year-on-year underlying3 revenue decline of 15%, excluding MarketMakers. The Lawyer is expected to report year-on-year underlying3 revenue decline of 22%.

Across both business units, the decline in revenues reflects the loss of event delegates and recruitment advertising sales due to the pandemic. However, in most cases, premium content revenues continue to increase with some recovery of subscription rates being experienced in the second half of the year. Of note, the Marketing Week Mini-MBA has continued to perform well with strong demand across its product offering; The Festival of Marketing, which ran as an online event this year, attracted over 2,700 delegates; and The Lawyer is anticipated to achieve a full-year renewal rate of 105%, demonstrating the continued value national and international law firms place in The Lawyer.

Financial

The full-year results will include a further exceptional charge of £0.6m in addition to the £0.6m of staff restructuring costs announced at the half year. Of the total £1.2m exceptional charge, £1.1m relates to the closure of MarketMakers and £0.9m had been paid by the end of Q3.

The Group has maintained prudent financial management, ensuring good cash collection and a reduction in debtor days. The current cash balance is at the same level as at the start of the year and £0.9m higher than the half year. This is despite paying out exceptional items of £3.4m relating to 2019 and £0.9m for the current year. As reported at the half year, the Group has also renegotiated its bank facility to provide up to £10m of borrowings with waived covenant tests to 30 September 2021.

The Board plans on providing guidance to analysts for 2021 along with a full-year trading update in January 2021.

Swag Mukerji, Chief Executive Officer, commented:

"Despite the impact of the COVID-19 pandemic, I am pleased that Centaur has remained resilient. Mini-MBA continues to grow very strongly, the Festival of Marketing successfully transitioned to an online format, and The Lawyer maintained strong renewals and increased its revenues from premium content. Although market conditions remain uncertain, Centaur has a strong cash position and a strengthening EBITDA margin, and we are confident that we will emerge from 2020 a more resilient and agile business. I would like to thank our amazing customers and staff and our patient shareholders for their support in these difficult times."

1 Continuing operations exclude the telemarketing activities of MarketMakers which were closed in August 2020.

2 Adjusted EBITDA is adjusted operating profit before depreciation and amortisation on a post-IFRS 16 basis. Adjusted results exclude adjusting items, such as exceptional items, as detailed in note 4 of the Interim Report for the period ended 30 June 2020.

3 Underlying revenues exclude the impact of Venture Business Research which was sold in the first half of 2019, and Marketing Week Live which was closed in the first half of 2019.

-Ends-

Enquiries:

Centaur Media plc

0207 970 4000

Swag Mukerji, Chief Executive Officer

Simon Longfield, Chief Financial Officer

Teneo

Paul Durman / Matthew Thomlinson

07793 522 824 / 07785 528 363

 

Note to editors

Centaur is an international provider of business information and specialist consultancy that inspires and enables people to excel at what they do, raising the standard for insight, interaction and impact. Leading brands include: Econsultancy, MiniMBA, Influencer Intelligence, Marketing Week, Festival of Marketing, Really B2B, Creative Review, Fashion & Beauty Monitor, Oystercatchers and The Lawyer.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEAPEXADDEFFA
Date   Source Headline
20th Feb 202410:49 amRNSDirector/PDMR Shareholding
18th Jan 20247:00 amRNSDirector/PDMR Shareholding
18th Jan 20247:00 amRNSTrading Update
19th Dec 202311:25 amRNSDirector/PDMR Shareholding
20th Nov 202311:22 amRNSDirector/PDMR Shareholding
26th Oct 20234:44 pmRNSDirector/PDMR Shareholding
22nd Sep 20239:30 amRNSDirector/PDMR Shareholding
20th Sep 20232:51 pmRNSDirector/PDMR Shareholding
19th Sep 202311:22 amRNSDirector/PDMR Shareholding
25th Aug 202311:00 amRNSDirector/PDMR Shareholding
21st Aug 202310:40 amRNSDirector/PDMR Shareholding
20th Jul 20237:00 amRNSInterim Results
17th Jul 20233:43 pmRNSDirector/PDMR Shareholding
21st Jun 20233:28 pmRNSDirector/PDMR Shareholding
1st Jun 202311:18 amRNSDirector Declaration
31st May 20234:35 pmRNSDirector Declaration
18th May 202311:44 amRNSDirector/PDMR Shareholding
10th May 20233:33 pmRNSResult of AGM
18th Apr 202311:47 amRNSDirector/PDMR Shareholding
12th Apr 20232:41 pmRNSDirector/PDMR Shareholding
4th Apr 20231:48 pmRNSAnnual Financial Report
21st Mar 20239:51 amRNSHolding(s) in Company
20th Mar 20233:33 pmRNSDirector/PDMR Shareholding
15th Mar 20237:00 amRNSPreliminary results for the year ended 31 Dec 2022
20th Feb 20239:30 amRNSDirector/PDMR Shareholding
31st Jan 20239:01 amRNSHolding(s) in Company
23rd Jan 20239:25 amRNSDirector/PDMR Shareholding
19th Jan 20237:00 amRNSTrading Update & Declaration of a Special Dividend
9th Jan 20234:40 pmRNSSecond Price Monitoring Extn
9th Jan 20234:35 pmRNSPrice Monitoring Extension
20th Dec 20222:19 pmRNSDirector/PDMR Shareholding
22nd Nov 20221:52 pmRNSDirector/PDMR Shareholding
16th Nov 20223:57 pmRNSDirector/PDMR Shareholding
24th Oct 20229:37 amRNSDirector/PDMR Shareholding
23rd Sep 202211:24 amRNSDirector/PDMR Shareholding
22nd Aug 20227:00 amRNSDirector/PDMR Shareholding
25th Jul 20225:13 pmRNSDirector/PDMR Shareholding
25th Jul 20229:50 amRNSDirector/PDMR Shareholding
20th Jul 20227:00 amRNSInterim Results
5th Jul 202210:30 amRNSDirector/PDMR Shareholding
23rd May 202210:33 amRNSDirector/PDMR Shareholding
16th May 20227:00 amRNSNon-Executive Director Appointment
12th May 202211:08 amRNSDirector/PDMR Shareholding
11th May 20223:09 pmRNSResult of AGM
21st Apr 202211:27 amRNSDirector/PDMR Shareholding
1st Apr 202211:54 amRNSAnnual Financial Report
25th Mar 202211:32 amRNSDirector/PDMR Shareholding
22nd Mar 20223:24 pmRNSDirector/PDMR Shareholding
18th Mar 20229:35 amRNSDirector/PDMR Shareholding
18th Mar 20229:31 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.